{"id":"NCT00415623","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient","officialTitle":"A Double-Blind, Comparative Study Between Amlodipine 5mg And 10mg In Patients With Essential Hypertension For Whom Amlodipine 5mg Is Insufficiently Effective","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2007-10","completion":"2007-10","firstPosted":"2006-12-25","resultsPosted":"2008-12-09","lastUpdate":"2021-02-11"},"enrollment":305,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Amlodipine","otherNames":[]},{"type":"DRUG","name":"Amlodipine","otherNames":[]}],"arms":[{"label":"Amlodipine 5mg","type":"ACTIVE_COMPARATOR"},{"label":"Amlodipine 10mg","type":"EXPERIMENTAL"}],"summary":"The changes in the trough systolic blood pressure from the baseline were assessed after 8 weeks of double-blind treatment with amlodipine 10 mg or amlodipine 5 mg","primaryOutcome":{"measure":"Change in Systolic Blood Pressure (SBP) From Baseline to Week 8","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"Amlodipine 5 mg","deltaMin":-7,"sd":null},{"arm":"Amlodipine 10 mg","deltaMin":-13.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":1},"locations":{"siteCount":14,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0531085&StudyName=A%20Comparative%20Study%20Between%20Amlodipine%2010mg%20And%205mg%20With%20Hypertension%20For%20Whom%205mg%20Is%20Insufficient"]},"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}